Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Alefacept does not effectively treat severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Low vitamin D can worsen pediatric alopecia areata.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Wigs significantly improve the well-being of people with severe hair loss.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

Low vitamin D levels are common in people with Alopecia Areata.

This therapy effectively treats resistant alopecia areata with minimal side effects.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.